Clinical trial
Oral Type I Collagen for Relieving Scleroderma
NCT00005675 · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH · Completed
Key facts
| NCT number | NCT00005675 |
|---|---|
| Title | Oral Type I Collagen for Relieving Scleroderma |
| Official title | Multicenter Phase II Trial of Oral Type I Bovine Collagen in Scleroderma |
| Lead sponsor | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH |
| Collaborators | Wayne State University University of California, Los Angeles UTHSC Medical University of South Carolina Beth Israel Medical Center University of Alabama at Birmingham Johns Hopkins University… |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Scleroderma, Connective Tissue Diseases |
| Intervention type | Drug |
| Interventions | Oral bovine type I collagen, Placebo |
| Enrollment | 168 |
| Start date | Apr 1, 2000 |
| Primary completion | May 1, 2005 |
| First posted | May 29, 2000 |
| Last update posted | May 25, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: